Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abiomed AbioCor Proxy Consent Policy Will Hasten Pace Of Trial Enrollment

This article was originally published in The Gray Sheet

Executive Summary

Abiomed's decision to allow relatives to provide informed consent for patient participation in the AbioCor artificial heart trial should ensure a greater number of patients will be eligible for implantation

You may also be interested in...



Abiomed Pumps Up Temporary Heart Assist Offerings With AB5000 Ventricle

Abiomed expects FDA's Sept. 25 approval of a PMA supplement for its AB5000 Ventricle biventricular cardiac assist system to help reinvigorate stagnant temporary cardiac assist capital equipment sales

Abiomed Pumps Up Temporary Heart Assist Offerings With AB5000 Ventricle

Abiomed expects FDA's Sept. 25 approval of a PMA supplement for its AB5000 Ventricle biventricular cardiac assist system to help reinvigorate stagnant temporary cardiac assist capital equipment sales

LVAD Market Estimated At 30,000, Thoratec Still Awaiting Coverage Decision

The potential U.S. market for artificial replacement hearts, assuming a two-year device lifespan, is about 36,000 patients per year, according to Abiomed

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018299

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel